140 related articles for article (PubMed ID: 38032068)
21. MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression.
Vishwamitra D; Li Y; Wilson D; Manshouri R; Curry CV; Shi B; Tang XM; Sheehan AM; Wistuba II; Shi P; Amin HM
Am J Pathol; 2012 May; 180(5):1772-80. PubMed ID: 22414602
[TBL] [Abstract][Full Text] [Related]
22. ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma.
Chaft JE; Rekhtman N; Ladanyi M; Riely GJ
J Thorac Oncol; 2012 Apr; 7(4):768-9. PubMed ID: 22425930
[No Abstract] [Full Text] [Related]
23. How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls.
Montella M; Lucà S; Ronchi A; Marino FZ; Caputo A; Sica A; Zeppa P; Franco R; Cozzolino I
Acta Cytol; 2023; 67(3):230-239. PubMed ID: 36634640
[TBL] [Abstract][Full Text] [Related]
24. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
Irshaid L; Xu ML
Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
[TBL] [Abstract][Full Text] [Related]
25. ALK+ large B cell lymphoma presenting as multiple bowel-obstructing, cytokeratin-positive tumours.
Petronilho S; Gournay V; Tauziede-Espariat A; Pina H; Pecriaux A; Drieux F; Poullot E; Briere J; Lechapt E; Gaulard P
Histopathology; 2022 Jun; 80(7):1128-1130. PubMed ID: 35238057
[No Abstract] [Full Text] [Related]
26. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
Gru AA; Voorhess PJ
Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579
[TBL] [Abstract][Full Text] [Related]
27. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
Atsaves V; Lekakis L; Drakos E; Leventaki V; Ghaderi M; Baltatzis GE; Chioureas D; Jones D; Feretzaki M; Liakou C; Panayiotidis P; Gorgoulis V; Patsouris E; Medeiros LJ; Claret FX; Rassidakis GZ
Br J Haematol; 2014 Nov; 167(4):514-23. PubMed ID: 25145835
[TBL] [Abstract][Full Text] [Related]
28. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587
[No Abstract] [Full Text] [Related]
29. Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
Jeong CJ; Lee HY; Han J; Jeong JY; Lee KS; Choi YL; Choi JY
Clin Nucl Med; 2015 Jan; 40(1):e34-9. PubMed ID: 25243942
[TBL] [Abstract][Full Text] [Related]
30. [Anaplastic lymphoma kinase-positive adenocarcinoma of lung: a cytopathologic analysis].
Chen Y; Gao L; Wang Y; Gui X; Zhang H; Wang L; Gu L; Feng L; Wu J; Yang W; Song Y; Zeng H; Zhang J; Bai Q; Zhou X; Ping B
Zhonghua Bing Li Xue Za Zhi; 2015 Sep; 44(9):628-32. PubMed ID: 26705277
[TBL] [Abstract][Full Text] [Related]
31. Detection of TRAF1-ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node.
Norimatsu Y; Akatsuka T; Matsuoka A; Hamada T; Mori I; Shiomi T; Mori N; Onishi K; Togashi Y; Inoue N; Takeuchi K; Sugaya M
J Dermatol; 2024 Jan; 51(1):120-124. PubMed ID: 37753577
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.
Cha YJ; Kim HR; Shim HS
J Transl Med; 2016 Oct; 14(1):296. PubMed ID: 27756333
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature.
Miranda RN; Lin L; Talwalkar SS; Manning JT; Medeiros LJ
Arch Pathol Lab Med; 2009 Sep; 133(9):1383-90. PubMed ID: 19722744
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase-rearranged lung adenocarcinoma.
Matsuura Y; Ninomiya H; Ichinose J; Nakao M; Okumura S; Nishio M; Mun M
J Thorac Cardiovasc Surg; 2022 Feb; 163(2):441-451.e1. PubMed ID: 33131892
[TBL] [Abstract][Full Text] [Related]
35. Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinoma.
Baldacci S; Grégoire V; Patrucco E; Chiarle R; Jamme P; Wasielewski E; Descarpentries C; Copin MC; Awad MM; Cortot AB
Lung Cancer; 2020 Aug; 146():366-369. PubMed ID: 32553554
[TBL] [Abstract][Full Text] [Related]
36. Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes.
Hoshino A; Nomura K; Hamashima T; Isobe T; Seki M; Hiwatari M; Yoshida K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Takita J; Kanegane H
Int J Hematol; 2015 Feb; 101(2):198-202. PubMed ID: 25416234
[TBL] [Abstract][Full Text] [Related]
37. Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation.
Sherman CG; Zielenska M; Lorenzana AN; Pulford KA; Mason DY; Hutchison RE; Thorner PS
Pediatr Dev Pathol; 2001; 4(2):129-37. PubMed ID: 11178628
[TBL] [Abstract][Full Text] [Related]
38. [Expression of microRNA in ALK-negative anaplastic large cell lymphoma and CD30-positive peripheral T cell lymphoma, not otherwise specified].
Wang C; Chen X; Chen X; He Y; Cao L
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):565-70. PubMed ID: 26705180
[TBL] [Abstract][Full Text] [Related]
39. ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two cases.
Fares AF; Lok BH; Zhang T; Cabanero M; Lau SCM; Stockley T; Patel D; Bradbury PA; Sacher A; Yasufuku K; Morash BA; Sabatini PJB; Nguyen LN; Leighl NB; Tsao MS; Shepherd FA; Liu G; Martins-Filho SN; Pal P
Lung Cancer; 2020 Aug; 146():350-354. PubMed ID: 32546380
[No Abstract] [Full Text] [Related]
40. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.
Horie R; Watanabe M; Ishida T; Koiwa T; Aizawa S; Itoh K; Higashihara M; Kadin ME; Watanabe T
Cancer Cell; 2004 Apr; 5(4):353-64. PubMed ID: 15093542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
